XM, Amerika Birleşik Devletleri'nde ikamet edenlere hizmet sunmamaktadır.
H
H

Hologic


Haberler

U.S. Hubspot, McDonald's, Tesla

U.S. RESEARCH ROUNDUP- Hubspot, McDonald's, Tesla July 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Hubspot, McDonald's and Tesla, on Tuesday. HIGHLIGHTS * Ameriprise Financial Inc AMP.N : KBW cuts target price to $460 from $470 * First Citizens Bancshares FCNCA.O : Jefferies raises target price to $2,460 from $2,005 * Hubspot Inc HUBS.N : TD Cowen cuts target price to $600 from $680 * McDonald's MCD.N : Piper
A
H
A
D
L
A
A
B

Hologic quarterly profit rises on strong demand for its women's health products

Hologic quarterly profit rises on strong demand for its women's health products July 29 (Reuters) - Medical technology company Hologic HOLX.O reported a higher third-quarter profit on Monday, driven by strong demand for its diagnostics and breast health products, but forecast revenue for the current quarter that fell short of Wall Street estimates.
H

Hologic Inc reports results for the quarter ended in June - Earnings Summary

Hologic Inc reports results for the quarter ended in June - Earnings Summary Hologic Inc HOLX.OQ reported quarterly adjusted earnings of $1.06​​ per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of 93 cents. The mean expectation of sixteen analysts for the quarter was for earnings of $1.02 per share.
H

Hologic Q3 Adjusted EBITDA USD 338.5 Million Vs. IBES Estimate USD 333.4 Million

BRIEF-Hologic Q3 Adjusted EBITDA USD 338.5 Million Vs. IBES Estimate USD 333.4 Million Jul 29 (Reuters) - Hologic Q3 adjusted net income USD 250.7 million vs. IBES estimate USD 240.7 million. Q3 net income USD 194.5 million Q3 operating margin 24.1% Q3 adjusted operating margin 31.2% Q3 adjusted gross margin 61.1% Q3 gross margin 55.4% Q3 revenue USD 1,011.4 million vs.
H

Hologic Inc <HOLX.OQ> expected to post earnings of $1.02 a share - Earnings Preview

Hologic Inc expected to post earnings of $1.02 a share - Earnings Preview Hologic Inc HOLX.OQ HOLX.O is expected to show a rise in quarterly revenue when it reports results on July 29 for the period ending June 30 2024 The Marlborough Massachusetts-based company is expected to report a 1.6% increase in revenue to $1 billion from $984.4 million a year ago, according to the mean estimate from 14 analysts, based on LSEG data.The company's guidance on May 2 2024, for the period ended June 30, was fo
H

Hologic Completes Acquisition Of Endomagnetics Ltd

BRIEF-Hologic Completes Acquisition Of Endomagnetics Ltd July 25 (Reuters) - Hologic Inc HOLX.O : HOLOGIC COMPLETES ACQUISITION OF ENDOMAGNETICS LTD Source text for Eikon: ID:nBw5Dy4qTa Further company coverage: HOLX.O
H

U.S. Colgate-Palmolive, McKesson, Microsoft

U.S. RESEARCH ROUNDUP-Colgate-Palmolive, McKesson, Microsoft July 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Colgate-Palmolive, McKesson and Microsoft, on Tuesday. HIGHLIGHTS * Colgate-Palmolive Co CL.N : TD Cowen initiates coverage with buy rating; PT $110 * DR Horton Inc DHI.N : JP Morgan raises target price to $180 from $163 * IQVIA Holdings Inc IQV.N : Baird raises target price to $251 from $235 * McKesso
C
H
M
M
T
V
Z
F
A
M
A
C
C
D
I

U.S. STOCKS Tempus AI, AeroVironment, Gold miners

BUZZ-U.S. STOCKS ON THE MOVE-Tempus AI, AeroVironment, Gold miners Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes were flat on Thursday, as investors assessed a string of economic data ahead of the Federal Reserve's closely watched inflation report, while Micron and pharmacy chain Walgreens Boots Alliance slumped on disappointing forecasts.
B
G
H
M
N
S
W
U
U
T
C
M

U.S. STOCKS Verona Pharma, McCormick, gold miners

BUZZ-U.S. STOCKS ON THE MOVE-Verona Pharma, McCormick, gold miners Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq slightly fell while other indexes were flat to slightly higher on Thursday, as a dip in Treasury yields after a string of economic data boosted megacap stocks.
B
G
H
M
S
W
U
U
T
M

U.S. STOCKS Elanco Animal Health, Levi Strauss, SM Energy

BUZZ-U.S. STOCKS ON THE MOVE-Elanco Animal Health, Levi Strauss, SM Energy Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures slipped on Thursday as a slump in Micron Technology after a lackluster forecast dragged down other semiconductor stocks, while caution ahead of economic data and a presidential debate also dented sentiment.
H
M
W
U
T

U.S. STOCKS International Paper, U.S. Bancorp, Micron Technology

BUZZ-U.S. STOCKS ON THE MOVE-International Paper, U.S. Bancorp, Micron Technology Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures slipped on Thursday as a slump in Micron Technology after a lackluster forecast dragged down other semiconductor stocks, while caution ahead of economic data and a presidential debate also dented sentiment.
H
M
W
U

Stephens starts Hologic with 'overweight' on balance sheet, M&A potential

BUZZ-Stephens starts Hologic with 'overweight' on balance sheet, M&A potential ** Stephens starts Hologic HOLX.O with "overweight", citing the women's health diagnostic equipment maker's strong balance sheet, low leverage ratio and potential for M&A ** Sets TP of $87 vs stock's last close of $72.27; stock flat in premarket trading ** "With leverage
H

U.S. Carnival, FedEx, Micron Technology

U.S. RESEARCH ROUNDUP-Carnival, FedEx, Micron Technology June 27 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Carnival, FedEx and Micron Technology, on Thursday. HIGHLIGHTS * Carnival Corp CCL.N : Macquarie raises target price to $25 from $24 * FedEx Corp FDX.N : Daiwa Capital Markets raises target price to $318 from $296 * Micron Technology Inc MU.O : JP Morgan raises target price to $180 from $130 * Unifirst Cor
A
E
G
H
H
M
N
S
A
C
C
E

Australia's Lumos Diagnostics jumps on $5 mln payment

BUZZ-Australia's Lumos Diagnostics jumps on $5 mln payment ** Shares of Lumos Diagnostics LDX.AX rise as much as 21.6% to A$0.045, set for its best day since Jan. 11 if gains hold ** Healthcare tech co says it has received a second payment of US$5.0 million from Hologic HOLX.O under the intellectual property (IP) agreement announced on 11 Jan. ** I
H

FDA classifies recall of Hologic's implant as 'most serious'

UPDATE 1-FDA classifies recall of Hologic's implant as 'most serious' Adds detail and background in paragraphs 2 to 6 May 22 (Reuters) - The U.S. Food and Drug Administration on Wednesday classified a recall of Hologic's HOLX.O devices that are implanted in soft tissue such as breast tissue as "most serious", and urged doctors to more actively monitor for side-effects.
H

FDA classifies recall of Hologic's implants for soft tissue as 'most serious'

FDA classifies recall of Hologic's implants for soft tissue as 'most serious' May 22 (Reuters) - The U.S. Food and Drug Administration on Wednesday classified a recall of Hologic's HOLX.O devices that are implanted in soft tissue such as breast tissue as "most serious". Reporting by Mariam Sunny in Bengaluru; Editing by Shailesh Kuber
H



Şartlar

Popüler varlıklar

Bildirim: XM Group şirketlerinin her biri yalnızca gerçekleştirme hizmeti ve online yatırım platformumuza erişim sağlar. Herhangi bir kişinin web sitesinde bulunan veya web sitesi üzerinden sağlanan içeriği görüntülemesine ve/veya kullanmasına izin vermek, bu hizmeti değiştirmek veya genişletmek amaçlı değildir ve bu hizmeti ne değiştirir ne de genişletir. Bu tür erişim ve kullanım her zaman şunlara tabidir: (i) Şartlar ve Koşullar; (ii) Risk Uyarıları ve (iii) Tam Bildirim. Bu nedenle bu tür içerikler yalnızca genel bilgi amacıyla sağlanır. Özellikle, online yatırım platformumuzun içeriklerinin finans piyasalarında herhangi bir işleme girmek için bir teşvik veya bir teklif olmadığını lütfen dikkate alın. Herhangi bir finans piyasasında yatırım yapmak sermayeniz için önemli düzeyde risk taşır.

Online yatırım platformumuzda yayınlanan tüm materyaller yalnızca eğitim/bilgilendirme amaçlıdır ve finansal tavsiye, yatırım vergisi veya yatırım tavsiyesi ve önerileri ya da yatırım fiyatlarımızın kaydı veya herhangi bir finansal enstrümanda işlem yapılması için bir teklif veya teşvik ya da talep edilmemiş finansal promosyonları içermez ve içerdiği şeklinde bir değerlendirme yapılmamalıdır.

Görüşler, haberler, araştırma, analizler, fiyatlar, diğer bilgiler veya bu web sitesinde bulunan üçüncü taraf sitelere verilen bağlantılar gibi her türlü üçüncü taraf içeriğin yanı sıra XM tarafından hazırlanan içerik de “olduğu gibi” esasına göre, genel piyasa yorumu olarak sağlanır ve bir yatırım tavsiyesi oluşturmaz. Herhangi bir içeriğin yatırım araştırması olarak yorumlanmasıyla ilgili olarak, içeriğin bağımsız yatırım araştırmasını desteklemek üzere tasarlanmış yasal gerekliliklere uygun hazırlanmadığını ve bu amacın güdülmediğini, aynı şekilde ilgili yasalar ve mevzuatlar kapsamında pazarlama iletişimi olarak değerlendirileceğini dikkate almalı ve kabul etmelisiniz. Buradan erişebileceğiniz Bağımsız Olmayan Yatırım Araştırması Bildirimimizi ve yukarıdaki bilgilerle ilgili Risk Uyarımızı okuduğunuzdan ve anladığınızdan emin olun.

Risk uyarısı: Sermayeniz risk altında. Kaldıraçlı ürünler herkese uygun olmayabilir. Lütfen Risk Bildirimi'mizi dikkate alın.